Hy Isenbaum
Directeur/Membre du Conseil chez Lunenfeld-Tanenbaum Research Institute
Profil
Hy Isenbaum is the Founder of Soberman, Isenbaum and Colomby and served as its Managing Partner until 1993.
He served as Chairman of Bioniche Life Sciences, Inc. until May 9, 2008.
He is a past Chairman of the Board of the Mount Sinai Hospital in Toronto and was appointed by the Ontario Ministry of Health as Ombudsman to the Medical Review Committee of the College of Physicians and Surgeons.
Currently, he serves on the Board of Directors of the Samuel Lumenfeld Research Institute in Toronto and is a Governor of the Weizman Institute of Science in Israel.
Mr. Isenbaum is a Chartered Accountant.
Postes actifs de Hy Isenbaum
| Sociétés | Poste | Début |
|---|---|---|
Lunenfeld-Tanenbaum Research Institute
 Lunenfeld-Tanenbaum Research Institute Miscellaneous Commercial ServicesCommercial Services Lunenfeld-Tanenbaum Research Institute engages in the provision of biomedical research services. It conducts research into various forms of cancer including colon, breast, pancreatic, prostate, neurological disorders and brain illnesses, women's and infants' health, diabetes, developmental biology, stem cell biology and tissue regeneration, mouse models of human disease, genomic medicine, and systems biology. The company was founded in 1985 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
| Weizmann Institute of Science | Corporate Officer/Principal | 09/07/2009 |
Anciens postes connus de Hy Isenbaum
| Sociétés | Poste | Fin |
|---|---|---|
| TELESTA THERAPEUTICS INC | Président | 09/05/2008 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
Lunenfeld-Tanenbaum Research Institute
Lunenfeld-Tanenbaum Research Institute Miscellaneous Commercial ServicesCommercial Services Lunenfeld-Tanenbaum Research Institute engages in the provision of biomedical research services. It conducts research into various forms of cancer including colon, breast, pancreatic, prostate, neurological disorders and brain illnesses, women's and infants' health, diabetes, developmental biology, stem cell biology and tissue regeneration, mouse models of human disease, genomic medicine, and systems biology. The company was founded in 1985 and is headquartered in Toronto, Canada. | Commercial Services |